论文部分内容阅读
重症肝炎是严重危害人民生命健康的一种凶险疾病。国内、外报道死亡率可高达70~90%。近年来国内以中西医结合进行抢救,死亡率有显著降低。1977年3月以来,我们试用以退黄合剂为主的中西医结合抢救重症肝炎37例、临床治愈率达51.35%,死亡率降为37.81%。一、诊断标准(参照广州中山医学院第三附属医院传染科标准)重症肝炎范围:包括急性肝坏死、亚急性肝坏死、慢性肝炎(或坏死后性肝硬化)并发肝细胞大块坏死。其具体诊断标准为:胆红质10毫克(或黄疸指数100单位)以上,又具备下列表现中任何一项,或胆红质虽不足10毫克,但具备下列表现中任何两项者:(一)出现精神神经症状;(二)肝脏缩小(或超声
Severe hepatitis is a dangerous disease that seriously endangers people’s lives and health. Domestic and foreign reports of mortality up to 70 to 90%. In recent years, the combination of Chinese and Western medicine for rescue, the mortality rate was significantly reduced. Since March 1977, we tried to rescue 37 patients with severe hepatitis treated with the combination of Chinese and Western medicine based on Quchuangji. The clinical cure rate was 51.35% and the mortality rate was reduced to 37.81%. First, the diagnostic criteria (refer to Guangzhou Zhongshan Medical College Third Affiliated Hospital of infectious diseases standards) Severe hepatitis range: Including acute liver necrosis, subacute hepatic necrosis, chronic hepatitis (or post-necrotic cirrhosis) complicated by hepatocellular necrosis. The specific diagnostic criteria are: 10 mg of bilirubin (or jaundice index of 100 units) or more, but also have any of the following performance, or less than 10 mg of bilirubin, but with any of the following: (a ) Appear neurotic symptoms; (B) the liver shrink (or ultrasound